相似文献
1
The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients.
Ann Transl Med. 2016 Sep;4(18):353. doi: 10.21037/atm.2016.08.32.
2
Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study.
Diagnostics (Basel). 2023 Mar 21;13(6):1190. doi: 10.3390/diagnostics13061190.
3
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Med Mycol. 2022 May 18;60(5). doi: 10.1093/mmy/myac026.
4
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches.
Mycoses. 2021 Sep;64(9):1002-1014. doi: 10.1111/myc.13274. Epub 2021 Apr 6.
5
Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis.
J Fungi (Basel). 2022 Feb 14;8(2):188. doi: 10.3390/jof8020188.
6
Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Ann Clin Microbiol Antimicrob. 2023 Oct 10;22(1):90. doi: 10.1186/s12941-023-00626-7.
7
Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Am J Respir Crit Care Med. 2020 Sep 1;202(5):708-716. doi: 10.1164/rccm.201910-1931OC.
8
Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
Crit Care. 2012 Jul 27;16(4):R138. doi: 10.1186/cc11443.
9
Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant. 2007 Apr;13(4):440-3. doi: 10.1016/j.bbmt.2006.11.014. Epub 2007 Feb 1.
10
Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
BMC Infect Dis. 2015 Jul 1;15:251. doi: 10.1186/s12879-015-0995-8.
引用本文的文献
1
Loss of pulmonary tissue protection and neutrophil microbicidal defects promote severe infection during influenza A virus infection.
Infect Immun. 2025 Sep 9;93(9):e0023425. doi: 10.1128/iai.00234-25. Epub 2025 Aug 11.
2
Treatment of Invasive Fungal Disease During Therapy for Acute Lymphoblastic Leukemia.
J Med Cases. 2025 May;16(5):174-180. doi: 10.14740/jmc5066. Epub 2025 May 28.
3
The Role of Quantitative Real-Time PCR in the Invasive Pulmonary Aspergillosis Diagnosis: A Retrospective Study.
Microorganisms. 2025 Feb 13;13(2):409. doi: 10.3390/microorganisms13020409.
4
Educational case: Coccidioidomycosis.
Acad Pathol. 2022 Aug 6;9(1):100042. doi: 10.1016/j.acpath.2022.100042. eCollection 2022.
5
Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Mycoses. 2021 Apr;64(4):364-371. doi: 10.1111/myc.13216. Epub 2021 Feb 13.
6
Fatal Disseminated Aspergillosis in a Patient with Systemic Lupus Erythematosus.
Case Rep Infect Dis. 2020 Feb 29;2020:9623198. doi: 10.1155/2020/9623198. eCollection 2020.
7
Idiopathic pulmonary fibrosis with chronic necrotizing pulmonary aspergillosis: a case report.
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2653-2656. eCollection 2019.
8
Reply to Verweij et al.
Clin Infect Dis. 2020 Jan 2;70(2):350-351. doi: 10.1093/cid/ciz568.
9
Galactomannan use in clinical practice: providing free testing is not the full answer.
Braz J Infect Dis. 2018 Jan-Feb;22(1):37-40. doi: 10.1016/j.bjid.2017.11.002. Epub 2017 Nov 22.
本文引用的文献
1
Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.
Crit Care. 2016 May 10;20(1):139. doi: 10.1186/s13054-016-1326-1.
2
Galactomannan detection for invasive aspergillosis in immunocompromised patients.
Cochrane Database Syst Rev. 2015 Dec 30;2015(12):CD007394. doi: 10.1002/14651858.CD007394.pub2.
3
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
Cochrane Database Syst Rev. 2015 Sep 7(9):CD009551. doi: 10.1002/14651858.CD009551.pub2.
4
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.
Crit Care. 2015 Jan 12;19(1):7. doi: 10.1186/s13054-014-0722-7.
5
Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Intern Med. 2014;53(21):2433-7. doi: 10.2169/internalmedicine.53.2381. Epub 2014 Nov 1.
6
What's new in invasive pulmonary aspergillosis in the critically ill.
Intensive Care Med. 2014 May;40(5):723-6. doi: 10.1007/s00134-014-3254-3. Epub 2014 Mar 20.
7
Galactomannan antigen assay from bronchoalveolar lavage fluid in diagnosis of invasive pulmonary aspergillosis in intensive care units patients.
Adv Biomed Res. 2014 Jan 27;3:68. doi: 10.4103/2277-9175.125851. eCollection 2014.
8
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.
Infection. 2014 Feb;42(1):141-51. doi: 10.1007/s15010-013-0539-3. Epub 2013 Oct 23.
9
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes.
BMC Infect Dis. 2013 Jan 23;13:29. doi: 10.1186/1471-2334-13-29.
10
Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
Crit Care. 2012 Jul 27;16(4):R138. doi: 10.1186/cc11443.
Zotero 插件